Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Fig. 3

Association of ESR1 and PIK3CA codon variants and alterations in oncogenic pathways with different involvement of the main metastatic sites. (lung, liver, soft tissue, CNS, lymph nodes and bone). The number of concomitant detected aberrations (NDA) of ESR1 and PIK3CA across different metastatic sites was represented next to each metastatic site

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us